Guillain-Barre syndrome following autologous bone marrow transplantation

R. Mudad, A. Hussein, W. P. Peters

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


The pathogenesis of the Guillain-Barre syndrome (GBS) is felt to involve alterations in cellular and humoral immune responses. We report the case of a 44-year-old female with stage IV breast cancer who developed GBS 2 days after receiving high dose chemotherapy with bone marrow and peripheral progenitor cell support, and granulocyte-macrophage colony stimulating factor (GM-CSF). Her clinical status stabilized with plasmapheresis. This report lends further support to hypotheses regarding cellular immune alterations in the pathogenesis of GBS.

Original languageEnglish (US)
Pages (from-to)167-169
Number of pages3
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Issue number2
StatePublished - Jan 1 1995
Externally publishedYes


  • Bone marrow transplantation
  • Guillain-Barre syndrome
  • Stage IV breast cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Guillain-Barre syndrome following autologous bone marrow transplantation'. Together they form a unique fingerprint.

Cite this